Report copyright - Deutsche Bank 41 Annual Health Care Conferencecontent.stockpr.com/.../LGND_DB+Healthcare+Conference_5.4.16_vF… · SRSE (2H’16) Sparsentan (FSGS - Kidney Disease) Phase 2 9.0%
Please pass captcha verification before submit form
Please pass captcha verification before submit form